Grifols (GRFS) Completes Acquisition of Talecris Biotherapeutics
Grifols, S.A. (NASDAQ: GRFS) announced that on June 1, 2011, Grifols completed its acquisition of Talecris Biotherapeutics Holdings Corp. In partial consideration for their shares, Talecris shareholders received Grifols non-voting shares that trade in the U.S. as Grifols ADSs. These new Grifols ADSs are listed on the NASDAQ Stock Exchange under the symbol "GRFS."
You May Also Be Interested In
- JPMorgan (JPM) to Sell Certain Global Special Opportunities Group Assets Valued at ~$1.3B
- Icahn Issues Release on Family Dollar Stores (FDO); Big Win, But Sees Other Bidders
- IBM (IBM) Rejects Offer for Chip-Making Unit - Bloomberg
Create E-mail Alert Related CategoriesCorporate News, Mergers and Acquisitions
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!